QQQ   431.80 (+0.17%)
AAPL   169.74 (-1.71%)
MSFT   416.09 (+0.59%)
META   501.05 (+0.16%)
GOOGL   154.93 (+0.05%)
AMZN   183.84 (+0.12%)
TSLA   157.21 (-2.64%)
NVDA   876.93 (+1.97%)
AMD   163.60 (+2.05%)
NIO   3.84 (-1.29%)
BABA   69.93 (-0.98%)
T   16.06 (-1.11%)
F   12.15 (-0.65%)
MU   122.14 (+0.63%)
GE   156.40 (+1.76%)
CGC   6.73 (-3.58%)
DIS   113.85 (+0.80%)
AMC   2.80 (+13.36%)
PFE   25.77 (-0.54%)
PYPL   63.63 (+0.19%)
XOM   118.77 (-0.76%)
QQQ   431.80 (+0.17%)
AAPL   169.74 (-1.71%)
MSFT   416.09 (+0.59%)
META   501.05 (+0.16%)
GOOGL   154.93 (+0.05%)
AMZN   183.84 (+0.12%)
TSLA   157.21 (-2.64%)
NVDA   876.93 (+1.97%)
AMD   163.60 (+2.05%)
NIO   3.84 (-1.29%)
BABA   69.93 (-0.98%)
T   16.06 (-1.11%)
F   12.15 (-0.65%)
MU   122.14 (+0.63%)
GE   156.40 (+1.76%)
CGC   6.73 (-3.58%)
DIS   113.85 (+0.80%)
AMC   2.80 (+13.36%)
PFE   25.77 (-0.54%)
PYPL   63.63 (+0.19%)
XOM   118.77 (-0.76%)
QQQ   431.80 (+0.17%)
AAPL   169.74 (-1.71%)
MSFT   416.09 (+0.59%)
META   501.05 (+0.16%)
GOOGL   154.93 (+0.05%)
AMZN   183.84 (+0.12%)
TSLA   157.21 (-2.64%)
NVDA   876.93 (+1.97%)
AMD   163.60 (+2.05%)
NIO   3.84 (-1.29%)
BABA   69.93 (-0.98%)
T   16.06 (-1.11%)
F   12.15 (-0.65%)
MU   122.14 (+0.63%)
GE   156.40 (+1.76%)
CGC   6.73 (-3.58%)
DIS   113.85 (+0.80%)
AMC   2.80 (+13.36%)
PFE   25.77 (-0.54%)
PYPL   63.63 (+0.19%)
XOM   118.77 (-0.76%)
QQQ   431.80 (+0.17%)
AAPL   169.74 (-1.71%)
MSFT   416.09 (+0.59%)
META   501.05 (+0.16%)
GOOGL   154.93 (+0.05%)
AMZN   183.84 (+0.12%)
TSLA   157.21 (-2.64%)
NVDA   876.93 (+1.97%)
AMD   163.60 (+2.05%)
NIO   3.84 (-1.29%)
BABA   69.93 (-0.98%)
T   16.06 (-1.11%)
F   12.15 (-0.65%)
MU   122.14 (+0.63%)
GE   156.40 (+1.76%)
CGC   6.73 (-3.58%)
DIS   113.85 (+0.80%)
AMC   2.80 (+13.36%)
PFE   25.77 (-0.54%)
PYPL   63.63 (+0.19%)
XOM   118.77 (-0.76%)

Candel Therapeutics (CADL) Insider Trading & Ownership

$5.88
+0.06 (+1.03%)
(As of 03:33 PM ET)

Candel Therapeutics (NASDAQ:CADL) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
44.60%
Number Of
Insiders Buying
(Last 3 Years)
5
Amount Of
Insider Buying
(Last 3 Years)
$22,610.98
Number Of
Insiders Selling
(Last 3 Years)
0
Get CADL Insider Trade Alerts

Want to know when executives and insiders are buying or selling Candel Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

CADL Insider Buying and Selling by Quarter

Candel Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/8/2022Francesca BaroneInsiderBuy1,238$1.61$1,993.18  
12/8/2022Jason AmelloCFOBuy3,100$1.69$5,239.00  
12/8/2022Joseph C PapaDirectorBuy3,014$1.70$5,123.80  
12/8/2022Paul Peter TakCEOBuy3,050$1.70$5,185.00  
12/8/2022Seshu TyagarajanCTOBuy3,000$1.69$5,070.00  
(Data available from 1/1/2013 forward)

CADL Insider Trading Activity - Frequently Asked Questions

Who is on Candel Therapeutics's Insider Roster?

The list of insiders at Candel Therapeutics includes Francesca Barone, Jason Amello, Joseph C Papa, Paul Peter Tak, and Seshu Tyagarajan. Learn more on insiders at CADL.

What percentage of Candel Therapeutics stock is owned by insiders?

44.60% of Candel Therapeutics stock is owned by insiders. Learn more on CADL's insider holdings.

Which Candel Therapeutics insiders have been buying company stock?

The following insiders have purchased CADL shares in the last 24 months: Francesca Barone ($1,993.18), Jason Amello ($5,239.00), Joseph C Papa ($5,123.80), Paul Peter Tak ($5,185.00), and Seshu Tyagarajan ($5,070.00).

How much insider buying is happening at Candel Therapeutics?

Insiders have purchased a total of 13,402 CADL shares in the last 24 months for a total of $22,610.98 bought.


More Insider Trading Tools from MarketBeat

This page (NASDAQ:CADL) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners